Skip to main content
KOAN logo

KOAN · Resonate Blends, Inc.

Track KOAN — free
$0.00 +0.00 (+33.33%) At close · Sep 2
Market Cap
$58,575
Shares
195.25M

KOAN metrics

55 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.00
Market cap
$58,575

Price action

19 metrics
Price change (1W)
-40.0%
Price change (30D)
-40.0%
Price change (3M)
-72.7%
Price change (6M)
-81.3%
Price change (YTD)
-90.3%
Price change (1Y)
-93.3%
Trailing year
Price change (5Y)
-99.9%
52-week high
$0.02
52-week low
$0.00
Change from 52-week high
-98.5%
Change from 52-week low
+0.0%
Annualized volatility
214.0%
Beta
-0.4
RSI (14D)
36.4
Price vs SMA 50
-47.6%
Price vs SMA 200
-87.5%
Avg volume (3M)
5.34M
Relative volume
0.4
Average dollar volume
$3,307

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
195.25M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 6,666.7%
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
0.0×
reciprocal yield 3,810.4%
P / book
FCF yield
-1,821.4%
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
1,952.1%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings

Profitability

9 metrics
Gross margin
65.5%
Operating margin
-72.2%
Trailing 12 months
Net margin
51.2%
Gross profit (TTM)
$1.46M
Operating profit (TTM)
−$1.61M
Net income (TTM)
$1.14M
Trailing 12 months
Diluted EPS (TTM)
$0.02
FCF margin
-47.8%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
+353.2%
Year over year
Net income growth YoY
Revenue (TTM)
$2.23M
Trailing 12 months
EPS growth YoY
Shares change YoY
+19.3%
Year over year · more shares
Revenue CAGR (3Y)
+312.4%
Revenue CAGR (5Y)
+12.5%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
Return on assets
95.1%
Debt / equity
Current ratio
0.2
EBITDA (TTM)
−$1.68M
Free cash flow (TTM)
−$1.07M
Quick ratio
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$18,117
Total assets
$1.20M
Total debt
$187,619

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$1.07M
Capital expenditures (TTM)
$1,000
R&D (TTM)
SG&A (TTM)
$181,931
Stock compensation (TTM)
R&D / revenue
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
13F filer change QoQ
Institutional ownership

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
21 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 897078 CUSIP 76090M102 Visit website